Streptococcus pneumoniae grows in biofilms during both asymptomatic colonization and infection. Pneumococcal biofilms on abiotic surfaces exhibit delayed growth and lower biomass and lack the structures seen on epithelial cells or during nasopharyngeal carriage.
KEYWORDS: RNA-Seq, Streptococcus pneumoniae, biofilms, hemoglobin
ABSTRACT
Streptococcus pneumoniae grows in biofilms during both asymptomatic colonization and infection. Pneumococcal biofilms on abiotic surfaces exhibit delayed growth and lower biomass and lack the structures seen on epithelial cells or during nasopharyngeal carriage. We show here that adding hemoglobin to the medium activated unusually early and vigorous biofilm growth in multiple S. pneumoniae serotypes grown in batch cultures on abiotic surfaces. Human blood (but not serum, heme, or iron) also stimulated biofilms, and the pore-forming pneumolysin, ply, was required for this induction. S. pneumoniae transitioning from planktonic into sessile growth in the presence of hemoglobin displayed an extensive transcriptome remodeling within 1 and 2 h. Differentially expressed genes included those involved in the metabolism of carbohydrates, nucleotides, amino acid, and lipids. The switch into adherent states also influenced the expression of several regulatory systems, including the comCDE genes. Inactivation of comC resulted in 67% reduction in biofilm formation, while the deletion of comD or comE had limited or no effect, respectively. These observations suggest a novel route for CSP-1 signaling independent of the cognate ComDE two-component system. Biofilm induction and the associated transcriptome remodeling suggest hemoglobin serves as a signal for host colonization in pneumococcus.
INTRODUCTION
Streptococcus pneumoniae causes ∼15 million cases of severe infections each year, leading to approximately half a million deaths in children (1, 2). Antibiotic resistance was reported in more than 30% of invasive pneumococcal disease in 2017 (3, 4), leading the World Health Organization to classify S. pneumoniae in 2017 as one of the top 12 priority pathogens (3–5).
S. pneumoniae establishment in the human upper respiratory tract involves the formation of bacterial aggregates developed into biofilms. In addition to playing a crucial stage in nasopharyngeal establishment, pneumococcal biofilms also take part in infections, such as rhinosinusitis (6), otitis media (7), and pneumonia (8–10). Local spread and bronchoaspiration may allow S. pneumoniae to breach the epithelial and endothelial barriers and penetrate tissues, providing access to the bloodstream. Circulating S. pneumoniae can then reach and invade the heart tissue, creating microscopic lesions within the myocardium that contain intracellular biofilms (11, 12). Biofilm growth serves a central role in the pneumococcal carriage and disease states by helping S. pneumoniae compete with the native flora, serving as reservoirs for spread, conferring antibiotic resistance, and facilitating the escape of the host immune responses (13, 14).
Several ex vivo systems for pneumococcal biofilms that facilitate dense bacterial communities with pronounced structures were developed. These include static or continuous flow bioreactors with live cultures of respiratory or mucosal epithelial cells (8–10, 15–18). Curiously, biofilm growth in vitro on abiotic surfaces is much more limited than in the ex vivo models mentioned above and requires various treatments such as replenished growth medium, an inoculum with logarithmic cells, or supplementation with a synthetic competence-stimulating peptide (CSP) (19, 20). Even under these conditions, S. pneumoniae grown in batch cultures develops biofilms on abiotic surfaces after a relatively long incubation period.
The aptitude for biofilm formation varies between pneumococcal isolates, and various bacterial elements impact this process. For example, capsule production is considered adversarial; unencapsulated strains produce more biofilms, mutants in genes influencing capsule production show increased biofilm formation (21), and biofilm pneumococci downregulate capsule production (19, 21–23). Free sialic acid supports S. pneumoniae biofilms (24), and inactivation of the bacterial neuraminidase, nanA, which cleaves terminal sialic acid from the host glycans, attenuates biofilm development (18). The choline residues of S. pneumoniae teichoic and lipoteichoic acids also play a role in biofilms, and the choline uptake operon, lic, contributes to the formation of the biofilm matrix (10, 13). S. pneumoniae’s choline-binding proteins (CBPs), which are anchored to the cell wall by binding the surface choline residues, include various enzymes and adhesins and interact with DNA in vitro (25). Incubation of S. pneumoniae with a high concentration of choline chloride inhibits the enzymatic activity, leads to the release of some CBPs from the surface, and attenuates biofilm formation (19). Still, the contribution of individual CBPs to biofilms varies. The loss of some CBPs (e.g., the murine enzymes lytA, lytC, and lytB or the adhesins cbpA, pcpA, and pspA) results in decreased biofilms, but inactivation of other CBPs (e.g., pce and cbpD) has no impact (25).
The two quorum-sensing systems, luxS/AI-2 and com, also impact biofilm development (15, 26). A mutant in luxS, an important enzyme-producing AI-2, produces less biofilm than the wild-type strain during middle ear infection in rats (27) and model systems involving either abiotic surfaces or human respiratory epithelial cells (15, 28). Similarly, inactivation of the comC gene (encoding the competence-stimulating peptide [CSP]) impairs biofilms on abiotic surfaces (29) and human respiratory epithelial cells (15). Interestingly, the AI-2 autoinducer is needed during the early stages of biofilm formation and the CSP-1 peptide promotes biofilm stability and maturation on abiotic surfaces (29). In summary, biofilm development by S. pneumoniae is multifactorial and multiple regulatory circuits influence it.
We recently discovered that addition of hemoglobin to the culture medium triggers unusually robust growth in S. pneumoniae and an extensive transcriptome shift that includes many metabolic genes and virulence factors necessary for nasopharyngeal colonization and lung infections (30). Here, we followed up on these observations and tested the hypothesis that hemoglobin also influences S. pneumoniae biofilm development.
RESULTS
Hemoglobin induces an early formation of S. pneumoniae biofilms in vitro.
The addition of human hemoglobin to iron-depleted Todd-Hewitt broth containing yeast extract (THYB), THYB with the iron chelator 2,2′-di-pyridyl [THYB-DP], or regular THYB (iron complete) facilitates vigorous pneumococcal growth that exceeded the one observed when the media were supplemented with free iron or heme (30). To better understand these observations, we tested here whether additional heme sources found in the host impact S. pneumoniae growth. THYB-DP was inoculated with S. pneumoniae D39 (serotype 2), and the cultures were grown in microtiter plates for 18 h in the presence of equine myoglobin or human serum. THYB-DP, as well as THYB-DP supplemented with free heme, iron, or hemoglobin, served as the controls (Fig. 1). The addition of 20 μM myoglobin or serum (5 to 40% [vol/vol]) reinstated growth in the iron-deprived medium that surpassed the one observed in medium complemented with iron or heme (Fig. 1A and data not shown). As with hemoglobin, the addition of myoglobin and serum improved growth also in standard THYB (Fig. 1B). Thus, S. pneumoniae in vitro cultivation is stimulated by myoglobin and serum when they are added as the sole iron source (i.e., in THYB-DP) or as an added nutrient (i.e., THYB), although not to the same extent as with hemoglobin.
FIG 1.

Myoglobin and serum promotes pneumococcal growth in iron-depleted and iron complete medium. THYB was inoculated with D39 cells grown on BAPs (18 h, starting OD600 of 0.05). Cultures were grown in microtiter plates. Growth is shown as follows. (A) THYB with 3 mM DP, THYB with DP and 2 mM FeNO3, 10 μM heme, 10% human serum, 20 μM equine myoglobin, or 20 μM hemoglobin. (B) THYB, THYB supplemented 80 μM FeNO3, 10 μM heme, 10% human serum, 20 μM equine myoglobin, or 20 μM hemoglobin. The data are representative of three independent experiments performed in triplicates; error bars indicate the standard deviations (SD).
We noticed that S. pneumoniae cultures grown for 18 h in THYB with hemoglobin formed a film that coated the wells, suggesting biofilm formation. Crystal violet staining confirmed that in the presence of hemoglobin, S. pneumoniae produced biofilms in both standard THYB (Fig. 2A) and iron-depleted THYB (Fig. 2B). Biofilm induction by hemoglobin occurred in a dose-dependent manner, starting with 0.5 μM hemoglobin in THYB (Fig. 2A) or 5 μM hemoglobin in THYB-DP (Fig. 2B). We did not observe biofilm formation with heme or free iron. Importantly, myoglobin or serum did not trigger biofilm formation, although they supported more pneumococcal growth. The addition of a control protein (bovine serum albumin [BSA], which has a molecular weight [MW] similar to that of hemoglobin) or denatured hemoglobin also did not stimulate biofilms. To control for the possible involvement of contaminant in the hemoglobin preparation, we filtered the hemoglobin solution using 10,000-MW cutoff and tested both fractions. Although filtered hemoglobin induced biofilms, the flowthrough did not (Fig. 2C). Finally, hemoglobin induced biofilms also in different S. pneumoniae strains (Fig. 2D), including the reference strain TIGR4 (serotype 4) and two clinical isolates (both serotype 6B). Therefore, biofilm induction is dependent on hemoglobin in its native form and conserved in multiple serotypes. The hemoglobin/heme binding protein, Spbhp-37, contributes to the iron acquisition from hemoglobin (31) and a D39 Δspbhp-37 mutant exhibits an attenuated growth compared to the parental strain also in regular THYB supplemented with hemoglobin (30). Examining the Δspbhp-37 mutant for biofilm formation revealed that it produced similar or slightly higher biofilm biomass compared to the wild-type strain (Fig. 2E), suggesting biofilm formation is independent of this heme uptake protein.
FIG 2.
Hemoglobin induces biofilm formation in S. pneumoniae. THYB was inoculated with S. pneumoniae cells grown on BAPs (OD600 = 0.05). Cultures were grown in microtiter plates; biofilms (18 h) produced by D39 (serotype 2) are shown. (A) THYB, THYB with 80 μM FeNO3, 10 μM heme, 20 μM equine myoglobin, 10% human serum, 20 μM BSA, or 0.5 to 20 μM hemoglobin. (B) THYB with 3 mM DP, THYB with DP and 2 mM FeNO3, 10 μM heme, 20 μM equine myoglobin, 10% human serum, 20 μM BSA, or 0.5 to 20 μM hemoglobin. (C) THYB with 20 μM denatured hemoglobin, filtered hemoglobin, or the flowthrough after hemoglobin filtration. (D) Biofilm formation by TIGR4 (serotype 4) and the clinical isolates 8655 and 3875 (serotype 6B) grown in THYB with 20 μM hemoglobin. The inset in panel A shows crystal violet staining following growth in THYB or THYB with hemoglobin (18 h). (E) Biofilm formation by D39 (solids) and isogenic Δspbhp-37 (stripes) strains grown in THYB or in THYB with 5 to 20 μM hemoglobin. The data show means ± the SD of at least two independent experiments, each performed in triplicates. The asterisks denote statistically significant differences: P ≤ 0.05 (THYB-Hb versus THYB in panels A to D and THYB-Hb WT versus Δspbhp-37 in panel E [Student t test]).
Pneumococci grown in THYB supplemented with hemoglobin formed noticeable biofilm biomass as early as 6 h postinoculation, peaking within 18 h of incubation. A lower level of biomass was observed at the 24- and 48-h time points (Fig. 3A). In contrast, cells grown in THYB produced little to no biofilms up to 48 h of incubation. In the presence of hemoglobin, we recovered 3.6-fold more live cells from the microplate surface compared to cultures that grew in THYB alone ([2.2 ± 0.57] × 108 versus [6.1 ± 1.94] × 107, respectively, P = 0.05). We also used a more sensitive, fluorescence-based method and confocal microscopy to investigate the timing of biofilm formation. Biofilms produced by strain D39 were visualized by staining the pneumococcal capsule and DNA. Confocal images (xy optical sections) revealed a rapid formation of biofilms that started at 2 h postinoculation and plateau at 8 h when D39 was incubated with hemoglobin (Fig. 3C).
FIG 3.
Hemoglobin induces unusually early and robust biofilms. THYB with 20 μM hemoglobin was inoculated with D39 grown on BAPs (starting OD600 = 0.05). (A) Cultures were grown in microtiter plates, and biofilm was quantified at different time points. The data are expressed as means ± the SD of at least two independent experiments each performed in triplicates. The asterisks denote statistically significant difference: P ≤ 0.05 (THYB-Hb versus THYB [Student t test]). (B and C) Confocal micrographs of biofilms produced by GFP-expressing D39 (28) grown in 8-well glass wells: THYB (B) or THYB with 20 μM hemoglobin (C). The DNA was treated with TO-PRO-3 (green), and the capsule was treated with Alexa Fluor 555-labeled anti-serotype specific antibodies (red).
Ferric iron (∼50 μM) promotes biofilms in S. pneumoniae grown in semisynthetic medium (C+Y) (26, 32). We examined biofilm formation in THYB or THYB-DP supplemented with ferric iron (50 μM to 2 mM). The iron did not impact biofilm formation under our experimental conditions, perhaps because of the different assay and growth conditions (THYB may contain more iron than C+Y). These observations are consistent with the finding that inactivation of spbhp-37 did not hamper biofilm formation (Fig. 2E). Still, since the iron stimulation of biofilm is dependent on luxS, we tested the impact of hemoglobin on growth and biofilm formation by a luxS mutant (28). As Fig. 4 shows, hemoglobin stimulated growth and biofilms in the ΔluxS and isogenic D39 parental strains to a similar extent. Together, these observations suggest that S. pneumoniae biofilm reaction to hemoglobin is mediated by a mechanism that is different from the reported response to ferric iron and is independent of luxS.
FIG 4.

S. pneumoniae growth and biofilm induction by hemoglobin are independent of luxS. (A and B) Growth (A) and biofilms (B) by isogenic D39 wild-type (red) and ΔluxS (purple) strains grown in THYB (empty symbols and bars) or in THYB with 20 μM hemoglobin (full symbols and bars). Biofilms were visualized and quantified after 18 h. NS, not statistically significant (+Hb, WT versus ΔluxS [Student t test]). The data are representative of at least two experiments performed in triplicates.
Human blood cells trigger biofilm formation in a Ply-dependent manner.
The vast majority of the host hemoglobin is within erythrocytes; we thus examined the impact of supplementing the growth medium with blood. The addition of washed blood cells (0.1 to 0.5%) to THYB triggered biofilm formation in the two test strains (D39 and TIGR4), although to a lower level than hemoglobin (Fig. 5A). Since Ply releases hemoglobin from blood cells in vitro (33–35), we sought to determine whether the pneumolysin is needed for the induction of biofilms by blood. Previously described ply knockouts in both D39 and TIGR4 backgrounds (36) did not produce biofilms when grown in THYB supplemented with blood (Fig. 5B), suggesting that the absence of hemolytic activity prevents biofilm induction by erythrocytes in the ply mutants. ply mutants grown with hemoglobin produced 10-fold more biofilm biomass than cells grown in THYB; hence, signaling of biofilms by hemoglobin remains. Still, the total biofilm biomass was lower compared to the wild-type strains grown with hemoglobin (Fig. 5C). Therefore, similar to our previous findings (36), the data suggest that Ply contributes to biofilm development independently of its hemolytic activity.
FIG 5.
Blood cells activate biofilm formation in a ply-dependent manner. Fresh medium was inoculated (starting OD600 = 0.05) with wild-type (WT) or Δply mutant (MT) isogenic pairs in D39 (blue) or TIGR4 (gray) strains grown on BAPs. The cultures were grown in microtiter plates, and biofilm formation at 18 h is shown. (A) Wild-type strains grown in THYB (empty) or THYB supplemented with 0.1 to 0.5% (vol/vol) washed human blood cells (filled). (B and C) Wild-type and mutant strains were grown THYB (empty) or THYB with 0.3% washed human blood cells (filled) (B) and in THYB (empty) or THYB with 20 μM hemoglobin (stripes) (C). The data are expressed as means ± the SD of at least two independent experiments, each performed in triplicates. The asterisks denote statistical significance: P ≤ 0.05 (THYB versus THYB-blood in panels A and B [Student t test; NS, not significant] or THYB versus THYB-blood WT versus MT in panels B and C [two-way analysis of variance [ANOVA]).
Compared to pneumococci that remain planktonic, S. pneumoniae transitioning into an adherent state modulates its transcriptome within 1 and 2 h after hemoglobin addition.
We recently described the significant growth enhancement and transcriptome remodeling hemoglobin is inducing in planktonic S. pneumoniae (30). Since we found that hemoglobin also triggers exceptionally early biofilm development, we aimed to probe the molecular events contributing to this prompt change in S. pneumoniae lifestyle. We rationalized that shortly after hemoglobin addition, genes needed for this transition will exhibit differential gene expression compared to pneumococci that remained planktonic. Hence, we investigated the S. pneumoniae transcriptome among planktonic and adherent cells 1 and 2 h after hemoglobin treatment by RNA-Seq (transcriptome sequencing). Since only a small number of pneumococci grown in THYB are found in an adherent state even after 18 h of incubation (Fig. 3A), we could not recover sufficient sessile cells from the cultures grown without hemoglobin at these early time points. In the absence of this group, we could not compare the transcriptome in early adherent state between cells grown with and without hemoglobin. Still, comparing between early adherent and planktonic pneumococci (both grown with hemoglobin) allows us to learn what takes place in cells that are just transitioning from free into sessile growth under the influence of hemoglobin.
Analysis of the global transcriptome revealed that newly attached pneumococci underwent an extensive transcriptome shift compared to cells that remained free living (see Table S1 in the supplemental material). Using quantitative reverse transcription-PCR (qRT-PCR) on a subset of regulated genes, we validated the RNA-Seq findings (see Fig. S3). Within the first hour after the addition of hemoglobin, 322 and 136 genes were up- and downregulated in adherent cells, respectively (Fig. 6A and B). Most of the transcriptome changes took place within the first hour after hemoglobin addition, and in the second hour, only 81 genes were induced, and 35 were repressed compared to cells that remained planktonic. Figure 6C illustrates the functional gene categories most influenced by the switch into an adherent state within 1 and/or 2 h posttreatment. These include genes involved in carbohydrate uptake and metabolism, as well as bacteriocins production and quorum sensing. The data also showed that 13 genes involved in translation were repressed in newly adherent cells. In addition, 17 genes that contribute to translation and three for transcription were activated in adherent cells compared to planktonic cells grown with hemoglobin. The choline moiety of S. pneumoniae teichoic acids is important for biofilm formation. We noted that five genes involved in choline uptake (proWX and proV), metabolism (pck), or binding (cbpF and cbpD) were activated and that the CBP, pcpA, was repressed (see Table S1). The expression of lytB, a peptidoglycan hydrolase that binds choline, was induced by hemoglobin during planktonic growth (30; accession number PRJNA626052) and remained expressed to a similar level in adherent pneumococci (data not shown; accession number PRJNA642413).
FIG 6.
S. pneumoniae transition from planktonic to biofilm growth in the presence of hemoglobin involves significant transcriptome remodeling. A Venn diagram (using R) of differentially expressed genes in adherent compared to planktonic cells (fold change ≥ 2) 1 h (pink and yellow [A and B, respectively]) and 2 h (green and purple [A and B, respectively]) after hemoglobin addition is shown. (A) Upregulated genes. (B) Downregulated genes. (C) Genes exhibiting altered expression (fold change ≥ 2) within 1 and/or 2 h of growth with hemoglobin are included.
Many genes that facilitate carbohydrate transport and metabolism were differentially expressed in sessile pneumococci compared to planktonic cells at the 1- and/or 2-h time point (Fig. 6C). Of the 63 induced genes, the glycerol uptake and metabolism operon, glpKOF (encoding a glycerol kinase, glycerol-3-phosphate oxidase, and a glycerol facilitator, respectively) exhibited the highest activation (Fig. 7A). Carbohydrate transporters and enzymes that were activated during the shift into adherent state included several systems for the uptake and catabolism of the carbohydrate moieties of the host glycans such as sialic acid, β-glucosides, galactose, and mannose (Fig. 7A). The capsule and saccharide synthesis genes (cps2P, cps2L, rfbC, and rfbB) were induced 2-fold in the first hour. We also noticed an activation (4- to 6-fold) of the glycogen synthesis operon, glgBCDA, which converts glucose 1-phosphate to glycogen. By reducing the cellular availability of glucose, glgBCDA induction can end up limiting the amount of UDP-GlcNAc required for capsule synthesis (37).
FIG 7.
Genes activated in S. pneumoniae transitioning into biofilms. The relative expression of selected genes that are upregulated in adherent versus planktonic cells (both grown with hemoglobin) at 1 h after hemoglobin addition (y axis) is plotted for D39 genes (x axis). (A) The log2-fold change (≥2-fold) of genes involved in the transport or metabolism of sugars derived from the host glycans. Shown are gene cluster encoding PTS (blue), enzymes (gray), transporter (orange), facilitator (green), and transcriptional regulator (white). Genes (within the cluster) encoding hypothetical proteins are not shown. (B) Genes or gene clusters involved in various functions. Region of diversity 12 (RD12) encodes a lantibiotic-synthesis gene cluster (38, 39).
In the first hour after hemoglobin treatment, the transition from planktonic to sessile growth was also associated with the induction of quorum-sensing and several two-component systems (TCS) (Fig. 7B). We previously found that the signaling peptide gene tprA/phrA (SPD_1746) is activated 2-fold in planktonic cells 1 h after hemoglobin addition (30; accession PRJNA626052). In sessile cells, we observed an earlier and more robust induction of tprA/phr along with the associated lantibiotic-synthesis gene cluster (encoded by region of diversity 12 [38, 39]). Notably, the TrpA/PhrA-controlled gene cluster is not expressed in regular laboratory medium, but its transcription is activated during heart infection (11). The lantibiotic immunity genes—blpYZ, the comCDE operon encoding the CSP-1 peptide, and the comDE TCS—were also induced, together with several genes from the com regulon (i.e., amiEDCA, cbpD, and cinA). Altogether, five TCSs were activated in the early stage of the switch into the adherent state reflecting the complexity of the transition in lifestyle.
In addition to the changes mention above, we noted the induction of enzymes acting on molecules found in the host tissue and extracellular matrix. These enzymes include putative hyaluronate lyase (SPD_0287) and heparinase (SPD_0300), as well as the neuraminidase, nanA (Fig. 7B), which is essential for biofilm formation in the nasopharynx (40). Genes involved in heme uptake (i.e., piuBC and spbhp-22 operon) (41–43) and heme binding (i.e., glnA and malX [44]) were also induced by S. pneumoniae cells recovered from the plate surface compared to free-living pneumococci (Fig. 7). A number of characterized and putative proteins involved in zinc acquisition and enzymes that require zinc were activated, as well in the early stages of sessile growth. On the other hand, the ferrichrome-binding protein, piaA (45), and the virulence factors, pfbA (46), pavA (47, 48), and pspA (49), were all repressed in biofilm cells compared to planktonic S. pneumoniae growing with hemoglobin. In summary, the S. pneumoniae switch into sessile growth is associated with a large shift in gene expression and involves a multifaceted regulatory scheme.
Biofilm formation in the presence of hemoglobin involves the comC gene but not the related TCS comDE.
To explore how the early transition in lifestyle S. pneumoniae exhibits in the presence of hemoglobin is coordinated, we tested mutants in regulatory genes that were upregulated in newly adherent pneumococci compare to planktonic cells (both grown with hemoglobin). Deletion mutants in comC (15, 29, 50), the TCS ciaRH, and yesMN and in the histidine kinase vicK (vicR is an essential gene) were tested for growth (see Fig. S1) and biofilm formation (see Fig. S2 and S8) with or without hemoglobin. Other than the ΔciaRH mutant, the mutants grew similarly to the wild type in THYB (see Fig. S1A) and created minimal but similar biomass on the plate surface after 18 h of incubation in THYB (see Fig. S2). The ciaRH mutant exhibited severely attenuated growth and a reduced biofilm biomass in THYB. Hemoglobin enhanced the growth of all strains, including that of the ciaRH mutant (see Fig. S1B). Compared to the wild-type strain, we did not observe a significant difference in biofilm generated by the ΔyesMN and ΔvicK mutants after 18 h of incubation (Fig. 8A). However, inactivation of ciaRH or comC resulted in a 37% (P = 0.01) or a 67% (P = 0.001) reduction, respectively.
FIG 8.

Biofilm formation in the presence of hemoglobin involves comC and is mostly independent of the comDE genes. THYB was inoculated with D39 wild-type and isogenic mutant strains grown on BAPs (starting OD600 = 0.05). (A and B) Biofilm biomass produced by S. pneumoniae grown after 18 h in THYB or THYB with 20 μM hemoglobin (Hb) (A and B), 200 ng/ml CSP1 (B), or Hb and CSP1 (B). The data are expressed as the means ± the SD of at least two independent experiments, each performed in triplicates. Asterisks denote statistical significance: P ≤ 0.05 (wild type versus mutant for each comparison of +Hb versus –Hb and of Hb versus Hb+CSP-1 [two-way ANOVA]).
As described above, comC inactivation was the most detrimental for biofilm development, and this phenotype was specific to THYB with hemoglobin. To explore this further, we examined individual deletion mutants in the histidine kinase CSP-receptor (comD) and the response regulator (comE) (29, 51, 52), which consists of the canonical pathway for CSP-1 signaling. Surprisingly, comD deletion resulted only in a minor reduction in biofilm production (∼20%, P = 0.04), and the deletion of comE had no impact (Fig. 8B). Supplementing the medium with synthetic CSP-1 complemented the ΔcomC and ΔcomD phenotypes but had no significant influence on biofilm production by the ΔcomE or the wild-type strains grown with or without hemoglobin (Fig. 8B). Together, the data demonstrate that hemoglobin triggers biofilms in a pathway that involves CSP-1 signaling. Importantly, in the presence of hemoglobin, comC contributes to biofilm development mostly independently of its cognate TCS comDE.
DISCUSSION
Biofilms are important for asymptomatic pneumococcal carriage as well as disease, and the pathogen alternates between planktonic and biofilm growth as it spreads from the upper respiratory tract and establishes infections at different sites (20, 22, 47, 53). The factors that promote one or the other lifestyle choices in S. pneumoniae are not fully understood. Iron availability affects biofilm formation in multiple bacterial pathogens, including S. pneumoniae. The heme in hemoglobin and other host proteins is the largest pool of iron within the human body (54–56). Here, we investigated the influence of the host hemoglobin and additional heme sources on S. pneumoniae growth and lifestyle.
Experiments with myoglobin and serum revealed that, like hemoglobin (30), they both stimulated pneumococcal planktonic growth in iron-depleted and iron-complete THYB beyond the level seen with free heme, iron, or in regular medium (Fig. 1). Therefore, growth induction is shared by several hemoproteins, although human hemoglobin has the most pronounced effect. Earlier analysis revealed an equal amount of intracellular iron in S. pneumoniae grown in THYB either with or without hemoglobin (30). This observation does not support the notion that the growth benefits of hemoproteins stem from increased iron bioavailability. Free iron and heme can be harmful due to the formation of reactive oxygen species and the lipophilic nature of heme (57, 58); it is possible that hemoproteins offer a less-damaging form of iron. Interestingly, the human pathogens Staphylococcus aureus and Streptococcus pyogenes exhibit a preference for heme iron over ferric iron (from transferrin or in a free form) (57, 58). It took longer for S. pneumoniae to initiate growth in THYB-DP with myoglobin compared to hemoglobin and serum. We used human hemoglobin and serum in this study; it is plausible that the strictly human pathogen, S. pneumoniae, is better adjusted to use human heme sources than the equine myoglobin.
S. pneumoniae, an avid colonizer of the human nasopharynx, exhibits surprisingly limited biofilm development on abiotic surfaces (8, 18, 53). One of the central discoveries we made in this study is that hemoglobin stimulates not only planktonic growth but also triggers robust biofilms in static models with multiple pneumococcal strains (Fig. 2). Control experiments established that biofilm activation is specific to hemoglobin and requires the protein in its native form. Notably, myoglobin and serum did not impact biofilm formation. Therefore, the hemoglobin-only activation of biofilms is probably mechanistically separated from growth induction that is shared by several hemoproteins (Fig. 1). In the presence of hemoglobin, pneumococcal biofilm growth on either polystyrene or glass surfaces was remarkably early (Fig. 3). The finding that the simple addition of hemoglobin triggered early and vigorous biofilm growth under growth conditions that otherwise do not facilitate significant biofilm formation, even after 48 h, implicates hemoglobin as one of the host factors that promote pneumococcal biofilm development during infection.
Growth in iron-restricted conditions stimulate biofilm in some pathogenic bacteria (e.g., Acinetobacter baumannii [59], S. mutans, and staphylococci [60]). Still, in other pathogens, such as Pseudomonas aeruginosa (61, 62), biofilm formation is activated by the presence of iron. A previous study showed that S. pneumoniae belongs to the second group and that iron promotes biofilms on abiotic surfaces in pneumococci grown in C+Y medium (26). While hemoglobin can provide S. pneumoniae with heme iron, the data suggest that, in our model system, hemoglobin induces biofilm in another way. Free iron or heme had no impact on biofilms in THYB (Fig. 2A). The Δspbhp-37 mutant was not impacted in hemoglobin induction of biofilms (Fig. 2E), although its growth on heme and hemoglobin iron is attenuated (30). Lastly, stimulation of pneumococcal biofilm by iron requires luxS, which promotes iron import, but the experiments with a ΔluxS mutant revealed no difference in hemoglobin-dependent biofilm formation (Fig. 4). We thus suggest that hemoglobin directly activates biofilms in S. pneumoniae independently of its ability to donate iron.
Hemoglobin is found in nasal sections as a result of local bleed caused by trauma, dry conditions, or the use of medications (63–65). Infections can also promote the release of hemoglobin into the cellular environment due to hemolytic activity and the host immune response. Pneumolysin (Ply) can release hemoglobin from erythrocytes (33–35). The addition of blood cells to the growth medium also promoted pneumococcal biofilms, and this activity required the ply gene (Fig. 5). Therefore, the presence of labile hemoglobin and blood in the upper respiratory tract secretions may stimulate biofilm formation and S. pneumoniae colonization. The same could take place also in other sites in which S. pneumoniae develops biofilms (e.g., the ear and the lungs).
Only two studies implicate hemoglobin as a host colonization factor. The addition of hemoglobin to a defined medium restored surface binding and adherence by the pathogenic yeast Candida albicans, which are otherwise observed only during growth in a complex medium or in vivo (66). This hemoglobin activity is independent of iron acquisition and is mediated by a receptor on the yeast surface. Similarly, hemoglobin in nasal secretions enhances nasal colonization by S. aureus and promotes surface adherence and biofilm formation in vitro (64). Staphylococcal biofilms were observed with either apo or holo hemoglobin, but not with free heme or myoglobin, and was independent of the staphylococcal hemoglobin receptors IsdB, and IsdH. Therefore, in both C. albicans and S. aureus, the colonization response is specific to hemoglobin and independent of the hemoglobin ability to provide the bacteria with heme iron. To the best of our knowledge, these are the only incidences in which the host hemoglobin was reported to impact microbial colonization. Still, the similarity between the response to hemoglobin in S. pneumoniae, S. aureus, and even by the yeast C. albicans, is significant and raises the possibility that other pathogens might have evolved to respond to the host hemoglobin in a similar manner.
Transcriptome analysis showed that newly adherent S. pneumoniae exhibits major changes in gene expression compared to cells that remained planktonic after hemoglobin treatment (Fig. 6). Newly sessile S. pneumoniae activated genes involved in the metabolism of carbohydrates, amino acids, lipids, and nucleotides, as well as enzymes involved in host interactions (e.g., nan A), redox, and cell wall functions. These pneumococci also reduced the expression of many genes involved in protein synthesis, the energy-generating ATP synthase, and some virulence factors (Fig. 6 and 7). The transcriptome changes in new adherent cells contain some overlap and trends similar to changes in gene expression recorded for early pneumococcal biofilms at later time points (20, 53, 67). Hence, these shifts in gene expression are likely needed early to facilitate the S. pneumoniae switch into sessile growth.
Hemoglobin induces in planktonic cells genes involved in the use of the host glycan as a carbon source (30) (accession PRJNA626052). In this study, the comparison between planktonic and sessile cells grown with hemoglobin revealed in adherent cells the activation of additional operons and gene clusters that facilitate the uptake and metabolism of glycan-derived sugars (Fig. 7A). Some of the phosphotransferase system (PTS) that were activated by hemoglobin in planktonic growth remained expressed to the same level in newly sessile cells (e.g., SPD_0293-95, which recognizes several sugars, including fructose and N-acetylglucosamine [data not shown]). Other systems (e.g., the galactose PTS encoded by SPD_0066-69) were further induced when cells grown with hemoglobin transitioned into an adherent state (data not shown). In summary, S. pneumoniae transitioning into sessile growth express many genes that allow it to take advantage of the sugars found in mucin and/or the epithelial surfaces, which are largely depleted of free glucose.
We previously noted that hemoglobin induces the expression of the zinc uptake gene, phtD, in planktonic S. pneumoniae (30). Here, we observed an additional activation of phtD in cells that switched into sessile growth, along with the induction of the other zinc uptake genes in S. pneumoniae and a number of zinc-dependent enzymes (Fig. 7B). These changes in gene expression, which suggest an increase in zinc uptake and use, are consistent with the positive correlation between zinc levels and pneumococcal aggregation and biofilm formation previously reported (68).
The induction of several TCS accompanied the pneumococcal transition into biofilms (Fig. 7B). Mutant analysis of selected genes demonstrated that only comC and ciaRH play a major role in the biofilm development under our experimental condition (Fig. 8A). The observation that the ciaRH mutant is also impacted in growth (see Fig. S1A) and biofilm development in regular THYB (see Fig. S2) raises the possibility that the reduction in biofilm development in the presence of hemoglobin is a reflection of a general growth/biofilm phenotype. The CiaRH TCS orchestrates the pneumococcal cell wall’s integrity and retention by preventing the lysis that is otherwise induced by stress and antibiotic treatment (69–72). Curiously, the addition of hemoglobin improved the mutant’s planktonic growth in THYB significantly (see Fig. S1B), raising the possibility that hemoglobin activates signaling downstream of the ciaRH signaling pathway.
The comC mutant exhibited a significant defect in biofilm growth in the presence of hemoglobin (Fig. 8A). Moreover, while exogenically added CSP-1 complemented the comC phenotype in THYB containing hemoglobin (Fig. 8B), it had no impact on biofilm development by the wild type or the comC mutant in regular THYB. Therefore, CSP-1 is not sufficient for triggering early biofilm development in S. pneumoniae grown in THYB. Still, this signaling peptide promotes the development of the biofilm growth induced by hemoglobin. The comC-encoded CSP is exported and orchestrates competence development by binding and activating the surface histidine kinase, ComD, which in turn relays the signal to the ComE response regulator (32). Interestingly, the data suggest that CSP-1 function in biofilm development under the influence of hemoglobin is mostly independent of the ComDE pathway (Fig. 8B). The comC-dependent but comDE-independent biofilm phenotype constituted a significant deviation from the canonical pathway for competence activation and, to the best of our knowledge, was not previously described. These intriguing findings suggest the presence of a new regulatory route for CSP in the hemoglobin induction of biofilms.
In summary, the addition of hemoglobin to S. pneumoniae culture grown on abiotic surfaces (without any other change in medium composition and growth condition) allows for rapid and robust biofilm development. Our findings suggest that the host hemoglobin serves as a colonization/attachment signal during infection, influencing the pneumococcal interchange between planktonic and sessile states. Hemoglobin promotes biofilms and colonization in two other microbial pathogens, suggesting a possible new theme in host-microbe interactions (64, 66).
MATERIALS AND METHODS
Bacterial strains and growth conditions.
The S. pneumoniae strains used in this study are listed in Table 1. Frozen S. pneumoniae stocks were prepared in the medium skim milk-tryptone-glucose-glycerin (STGG), as described previously (73), and kept at −80°C. S. pneumoniae STGG stocks were plated on tryptic soy blood agar plates (BAPs) and incubated overnight at 37°C under microaerophilic conditions. S. pneumoniae was grown in Todd-Hewitt broth containing 0.5% (wt/vol) yeast extract (THYB). One or more of the following supplements were added to the growth medium as indicated: the iron chelator 2,2′-di-pyridyl (ACROS Organics); bovine hemin, BSA, human hemoglobin, and equine myoglobin (Mb; all from Sigma-Aldrich); ferric nitrate nonahydrate (FeNO3; Fisher Scientific); whole human blood (BioIVT); human serum (Innovative Research); and competence-stimulating peptide (CSP1, 200 ng/ml; Annaspec). The antibiotics erythromycin (0.5 μg/ml), chloramphenicol (4 μg/ml), and tetracycline (1 μg/ml) were added to the BAPs when needed. In some experiments, heat-inactivated hemoglobin (99°C for 5 min) or filtered hemoglobin (Amicon Ultra centrifugal filters, MWCO 10,000) or the flowthrough fraction was added to the growth medium.
TABLE 1.
Strains and plasmids used in this study
| Strain or plasmid | Description | Source or reference(s) |
|---|---|---|
| Strains | ||
| S. pneumoniae | ||
| D39 | Avery strain, clinical isolate (capsular serotype 2), CSP1 | 79, 80 |
| D39 (SPJV01) | GFP-expressing strain, D39/pMV158GFP (Tetr) | 28 |
| TIGR4 | Invasive clinical isolate (capsular serotype 4), CSP2 | 81 |
| 8655 | Invasive isolate (capsular serotype 6B), CSP2 | CDC |
| 3875 | Invasive isolate (capsular serotype 6B), CSP1 | CDC |
| Δspbhp-37 (SPZE1) | D39 Δspbhp-37::ermB (Eryr) | 30 |
| Δply (SPJV14) | D39 Δply::ermB (Eryr) | 36 |
| Δply (SPJV18) | TIGR4 Δply::ermB (Eryr) | 36 |
| ΔluxS (SPJV05) | D39 ΔluxS::ermB (Eryr) | 28 |
| ΔcomC (SPJV10) | D39 ΔcomC::ermB (Eryr) | 15 |
| ΔcomD (SPJV31) | D39 ΔcomD::catP (Cmr) | This study |
| ΔcomE (SPJV32) | D39 ΔcomE::catP (Cmr) | This study |
| ΔciaRH (SPZE2) | D39 ΔciaRH::ermC (Eryr) | This study |
| ΔyesMN (SPZE3) | D39 ΔyesMN::ermC (Eryr) | This study |
| ΔvicK (SPZE4) | D39 ΔvicK::cat194 (Cmr) | This study |
| E. coli | ||
| OneShot Top10 | Cloning host | Invitrogen |
| Plasmids | ||
| pMV158GFP | S. pneumoniae mobilizable plasmid containing the green fluorescent protein gene | 82 |
| pJRS233 | Temperature-sensitive shuttle vector encoding the ermC gene (Eryr) | 83 |
| pDC123 | Gram-positive vector encoding the cat-194 gene (Cmr) | 84 |
| pAF105 | pUC19-derived plasmid with the ΔciaRH::ermC allele and the bla gene (Ampr) | This study |
| pAF106 | pUC19-derived plasmid with the ΔvicK::cat194 allele and the bla gene | This study |
| pAF108 | pUC19-derived plasmid with the ΔyesMN::ermC allele and the bla gene | This study |
Growth assays.
Fresh THYB medium (with or without supplements) was inoculated with S. pneumoniae cells (serotypes 2, 4, and 6; Table 1) collected from BAPs after 18 h of incubation (starting culture optical density at 600 nm [OD600] of 0.05). Cell cultures (200 μl/well) were grown in 96-well microtiter plates (Costar 3595; Corning) incubated at 37°C. The culture OD600 was recorded at 1-h intervals for the indicated times using (SpectraMax M2 spectrophotometer; Molecular Devices). For each growth condition, we used wells containing only the medium (and supplements when appropriate) as the blank. Bacterial growth was tested in triplicates.
Biofilms in microtiter plates.
Fresh THYB medium (with or without supplements) was inoculated with S. pneumoniae cells (serotypes 2, 4, and 6) as described above, and the cultures were grown in 96-well microtiter plates for up to 48 h. In some experiments, whole human blood suspensions (0.1, 0.3, and 0.5%) were prepared in sterile phosphate-buffered saline (PBS), washed three times by centrifugation (500 × g, 5 min, 4°C), and the blood cells were suspended in THYB prior to inoculation with S. pneumoniae. In other experiments, normal pooled human serum was added to the THYB (2.5 to 40%), and the medium was filter sterilized and used in the assay. Crystal violet staining was used to quantitate the biofilm biomass at different time points, as indicated in the text. The growth medium was removed by aspiration, and plates were washed five times with ddH2O and allowed to dry for 15 min. Crystal violet (0.1%) was added, and the plates were incubated for 15 min with slow shaking (Lab-Line Maxi-Rotator). The wells were washed and allowed to dry for 15 min before the addition of 95% ethanol. The suspensions were mixed vigorously by pipetting after 15 min of incubation at room temperature. The absorbance at 590 nm was determined by a SpectraMax M2 spectrophotometer (Molecular Devices). To determine viability, biofilms were washed twice with sterile PBS at designated time points, and the plates were sonicated for 15 s in a Cole-Parmer ultrasonic cleaner, followed by vigorous pipetting; the cells were then collected. Cell counts (CFU/ml) were determined by plating into BAPs.
Confocal microscopy.
Overnight BAP cultures of D39 were used to inoculate 8-well glass plates as with the microtiter assay described above. At the indicated time points, the wells were washed three times with PBS, fixed with 2% paraformaldehyde, and stained at room temperature, as previously described (15). The capsule was stained with a rabbit polyclonal antibody against serotype 2 capsule (i.e., D39) conjugated with Alexa Fluor 555 (Molecular Probes, Invitrogen) for 30 min. Nucleic acids were stained with TO-PRO-3 (Molecular Probes) for 15 min. After three washes with PBS, the plates were mounted with Vectashield mounting medium (Vector Laboratories) and analyzed with a Zeiss LSM 510 confocal microscope. Confocal images were analyzed with an LSM image browser, v4.0.2.121.
RNA preparation from early adherent pneumococci 1 and 2 h after hemoglobin treatment.
Cell growth and RNA preparation were performed, as we recently described in Akhter et al. (30). Briefly, fresh THYB was inoculated with S. pneumoniae D39 (serotype 2) cells from frozen logarithmic stocks (starting culture OD600 of 0.02), and the cultures were grown in 12-well microtiter plates (2 ml/well) at 37°C. Next, 20 μM hemoglobin (in 0.9% saline) or 0.9% saline (negative control) was added to the growing cells at the early logarithmic phase (after ∼3 h, OD600 = 0.2 to 0.3). The cultures were allowed to continue to grow and the medium was removed 1 or 2 h after hemoglobin treatment, and the plates were washed with sterile PBS (1 ml). Adherent cells were released by sonication in PBS (1 ml) for 15 s. Samples were collected and processed with RNA protect reagent (Qiagen) according to the manufacturer’s recommendations, and the pellet was stored at –80°C. Cell samples were suspended in 700 μl of TRIzol with 300 mg of acid-washed glass beads (Sigma Life Science), followed by disruption by vortexing. Total RNA (two biological replicates) was prepared by using a Direct-Zol RNA MiniPrep kit (Zymo Research). DNA was removed by using a Turbo DNase-free kit (Life Technologies). rRNA was eliminated with a Ribo-Zero Magnetic kit for Gram-positive bacteria (Epicenter). RNA Quality and quantity were assessed by using a 2100 Bioanalyzer (Agilent) and a NanoDrop 8000 spectrophotometer (Thermo Scientific), respectively.
RNA-Seq analysis.
RNAseq Directional RNA-Seq libraries were created using the ScriptSeq v2 RNA-Seq library preparation kit (Illumina) according to the manufacturer’s instructions. A rapid-run 100-bp single-read DNA sequencing was performed at the Institute for Bioscience and Biotechnology Research sequencing facility at the University of Maryland—College Park using the Illumina HiSeq 1500 platform. Data were generated in the standard Sanger FastQ format, and raw reads were deposited with the Sequence Read Archive at the National Center for Biotechnology Institute (accession number PRJNA642413). Read quality was evaluated using FastQC software, and mapping against the S. pneumoniae D39 genome was completed using Bowtie package alignment software (74). The read count or raw count data for all genes were acquired using the Featurecount package (75). These raw count data files were then used in the DESeq2 package (76) to calculate differential expression analysis 1 and 2 h after hemoglobin addition between newly adherent (samples collected as described above) and planktonic S. pneumoniae (data derived from four biological replicates collected and analyzed as described in Akhter et al. [30]). The DESeq2 package was used for differential expression analysis with raw count data for all samples for pairwise comparison.
qRT-PCR analysis.
Quantitative reverse transcription-PCR analysis was carried out using a Power SYBR Green RNA-to-Ct 1-Step kit (Applied Biosystems) and a 7500 Fast Real-Time PCR machine (Applied Biosystems) according to the manufacturers’ specifications. A total of 25 ng of RNA (from two independent replicates) was used per qRT-PCRs, and each reaction was performed in duplicate. The primers used for qRT-PCR are listed in Table 2. The relative expression was normalized to the endogenous control gyrB gene, and fold changes were calculated using the comparative 2–ΔΔCT method. qRT-PCR validation of RNA-Seq done with RNA samples from planktonic S. pneumoniae is described in Akhter et al. (30).
TABLE 2.
Primers used in this study
| Target | Primer, sequence (5′–3′) | Comment |
|---|---|---|
| pUC19-L | ZE 774-L, TGATTCTCGGCATGCAAGCTTGGCGTAATCAT | ciaRH deletion |
| ZE 775-R, TAAGACTCGTACCGAGCTCGAATTCACTGGCC | ||
| 5′ region of ciaRH | ZE 776-L, CTCGGTACGAGTCTTATCTGGTGGTTTCAGCT | ciaRH deletion |
| ZE 777-R, CACACGGTCATGAGAAACTCCTCCTTATTAAA | ||
| ermC | ZE 778-L, TTCTCATGACCGTGTGCTCTACGACCAAAACT | ciaRH deletion |
| ZE 779-R, GCATTATCCCGTGGAATTCCCCCCTTAACTTA | ||
| 3′ region of ciaRH | ZE 780-L, TTCCACGGGATAATGCCGTCAAGTATACTGAG | ciaRH deletion |
| ZE 781-R, TGCATGCCGAGAATCATGCCCGTAAGAAAATT | ||
| pUC19-L | ZE 798-L, ATGTTTTGGGCATGCAAGCTTGGCGTAATCAT | yesMN deletion |
| ZE 799-R, CTTGAGACGTACCGAGCTCGAATTCACTGGCC | ||
| 5′ region of yesMN | ZE 800-L, CTCGGTACGTCTCAAGCAACCTGATTTTCTAT | yesMN deletion |
| ZE 801-R, CACACGGTATCATTTCGAACATAGAGGTCATC | ||
| ermC | ZE 802-L, GAAATGATACCGTGTGCTCTACGACCAAAACT | yesMN deletion |
| ZE 803-R, TATTGACCCCGTGGAATTCCCCCCTTAACTTA | ||
| 3′ region of yesMN | ZE 804-L, TTCCACGGGGTCAATACCGTATGAATGAAAAT | yesMN deletion |
| ZE 805-R, TGCATGCCCAAAACATAGCCAACGTAAGTATA | ||
| pUC19-L | ZE 782-L, AGAAAGAAGGCATGCAAGCTTGGCGTAATCAT | VicK deletion |
| ZE 783-R, CACAATAGGTACCGAGCTCGAATTCACTGGCC | ||
| 5′ region of vicK | ZE 784-L, CTCGGTACCTATTGTGTCTTCTGACTATTTTT | vicK deletion |
| ZE 785-R, CATCGGTCTCAAGCATTATTTCTCATGTAATA | ||
| cat-194 | ZE 786-L, ATGCTTGAGACCGATGATGAAGAAAAGAATTT | vicK deletion |
| ZE 787-R, TCACTCTTTTATAAAAGCCAGTCATTAGGCCT | ||
| 3′ region of vicK | ZE 788-L, TTTTATAAAAGAGTGAATACGGCAAGGGTTCA | vicK deletion |
| ZE 789-R, TGCATGCCTTCTTTCTATATCTCTGTCAATGG | ||
| 5′ region of comD | SL91, CTTACCAATAATGCGC | comD deletion |
| SL98, CGGTTTTCTAATGTCACTAACTAGACAAATCATTAGATTTAAGAGG | ||
| 5′ region of comE | SL99, GCTTATCGATACCGTCGAAAAGGATAAAGGTAGTCC | comD deletion |
| SL96, GGTTGTCAAAATTCTTCC | ||
| catP | SL97, CCTCTTAAATCTAATGATTTGTCTAGTTAGTGACATTAGAAAACCG | comD deletion |
| SL100, GGACTACCTTTATCCTTTTCGACGGTATCGATAAGC | ||
| 5′ region of comE | MS93, TAGTCAAAGCAAATCATAAATTGCG | comE deletion |
| MS99, GCTTATCGATACCGTCGAATATTCTCTCTAGTCTCACTTGATGTTC | ||
| 3′ region of comE | MS100, CGGTTTTCTAATGTCACTAACTCTCAAAAGTGATTGACAATTAGC | comE deletion |
| MS96, CATGCTCATCACAAAAGAGACGC | ||
| catP | MS101, GAACATCAAGTGAGACTAGAGAGAATATTCGACGGTATCGATAAGC | comE deletion |
| MS102, GCTAATTGTCAATCACTTTTGAGAGTTAGTGACATTAGAAAACCG | ||
| comD | ZE 856-L, GATTTGGTTCGTATCATGAGC | qRT-PCR |
| ZE 857-R, GGAGTCATCGTCATTTTACATG | ||
| yesM | ZE 858-L, GATTCCCAAGTTTACCTTGCAAC | qRT-PCR |
| ZE 859-R, CGACATTCCTCTACCATTATCG | ||
| piuB | ZE 864-L, TGATTTCGACCAGCAGACCTG | qRT-PCR |
| ZE 865-R, CTGTACTCGGTGCAGCAAACTG | ||
| phrA | ZE 874-L, GTTACATTTGCATTGCTAGGTG | qRT-PCR |
| ZE 875-R, TTGCACTCGAATCTCCAATTG | ||
| SPD_1587 | ZE 665-L, ATGCAGGCAGAAGGAATAGAAG | qRT-PCR |
| ZE 666-R, TTGGCAAACAACTTCTTCATC |
Construction of mutant strains.
The plasmids used in this study are listed in Table 1, and the primers are shown in Table 2. To generate a deletion mutation in ciaRH, yesMN, and vicK genes, mutant alleles containing an antibiotic resistance gene flanked by the 5′ and 3′ genomic regions of the targeted genes were prepared for each mutant using the GeneArt seamless cloning kit (Thermo Fisher Scientific). Briefly, the appropriate genomic segments were amplified from the D39 chromosome. The ermC gene, cat-194, and the pUC19 vector were amplified from plasmids pJRS233, pDC123, and pUC19-L, respectively. All PCR fragments were purified using a Minelute PCR purification kit (Qiagen) and cloned into One-Shot Top10 E. coli, generating plasmids pAF105 (ΔciaRH), pAF106 (ΔvicK), and pAF108 (ΔyesMN). The ΔcomD and ΔcomE mutants were prepared by replacing the wild-type gene with a truncated fragment containing the catP gene. This fragment was prepared by PCR splicing, as previously described (77). The DNA fragments containing the mutant alleles were amplified from and introduced into competent D39 cells according to standard protocols (78). The mutants were selected on BAPs containing the appropriate antibiotics, and the mutation was confirmed by PCR.
Data availability.
We have deposited all RNA-Seq raw sequencing reads with the Sequence Read Archive at the National Center for Biotechnology Institute (accession number PRJNA642413) for public availability.
Supplementary Material
ACKNOWLEDGMENTS
E.W. was supported by the Graduate Assistance in Areas of National Need (GAANN) fellowship grant number P200A150308. J.E.V. was in part supported by grants from the National Institutes of Health (R21AI112768-01A1 and 1R21AI144571-01).
We thank Brenda Antezana and Sarah Lohsen from Emory University for their assistance in preparing some mutants.
Footnotes
Supplemental material is available online only.
REFERENCES
- 1.Levine OS, Klugman KP. 2009. Editorial: breathing new life into pneumonia epidemiology. Am J Epidemiol 170:1067–1068. doi: 10.1093/aje/kwp316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Walker CLF, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, O’Brien KL, Campbell H, Black RE. 2013. Global burden of childhood pneumonia and diarrhoea. Lancet 381:1405–1416. doi: 10.1016/S0140-6736(13)60222-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Chenoweth CE, Saint S, Martinez F, Lynch JP, 3rd, Fendrick AM. 2000. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. Mayo Clin Proc 75:1161–1168. doi: 10.4065/75.11.1161. [DOI] [PubMed] [Google Scholar]
- 4.Kim L, McGee L, Tomczyk S, Beall B. 2016. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective. Clin Microbiol Rev 29:525–552. doi: 10.1128/CMR.00058-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Centers for Disease Control and Prevention. 2019. Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services/CDC, Atlanta, GA. [Google Scholar]
- 6.Sanderson AR, Leid JG, Hunsaker D. 2006. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 116:1121–1126. doi: 10.1097/01.mlg.0000221954.05467.54. [DOI] [PubMed] [Google Scholar]
- 7.Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich GD, Kerschner JE. 2006. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296:202–211. doi: 10.1001/jama.296.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Marks LR, Parameswaran GI, Hakansson AP. 2012. Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo. Infect Immun 80:2744–2760. doi: 10.1128/IAI.00488-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sanchez CJ, Shivshankar P, Stol K, Trakhtenbroit S, Sullam PM, Sauer K, Hermans PW, Orihuela CJ. 2010. The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog 6:e1001044. doi: 10.1371/journal.ppat.1001044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Trappetti C, Ogunniyi AD, Oggioni MR, Paton JC. 2011. Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease. PLoS One 6:e19844. doi: 10.1371/journal.pone.0019844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shenoy AT, Brissac T, Gilley RP, Kumar N, Wang Y, Gonzalez-Juarbe N, Hinkle WS, Daugherty SC, Shetty AC, Ott S, Tallon LJ, Deshane J, Tettelin H, Orihuela CJ. 2017. Streptococcus pneumoniae in the heart subvert the host response through biofilm-mediated resident macrophage killing. PLoS Pathog 13:e1006582. doi: 10.1371/journal.ppat.1006582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Brown AO, Mann B, Gao G, Hankins JS, Humann J, Giardina J, Faverio P, Restrepo MI, Halade GV, Mortensen EM, Lindsey ML, Hanes M, Happel KI, Nelson S, Bagby GJ, Lorent JA, Cardinal P, Granados R, Esteban A, LeSaux CJ, Tuomanen EI, Orihuela CJ. 2014. Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function. PLoS Pathog 10:e1004383. doi: 10.1371/journal.ppat.1004383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Domenech M, Garcia E, Moscoso M. 2012. Biofilm formation in Streptococcus pneumoniae. Microb Biotechnol 5:455–465. doi: 10.1111/j.1751-7915.2011.00294.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Shak JR, Vidal JE, Klugman KP. 2013. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol 21:129–135. doi: 10.1016/j.tim.2012.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Vidal JE, Howery KE, Ludewick HP, Nava P, Klugman KP. 2013. Quorum-sensing systems LuxS/autoinducer 2 and Com regulate Streptococcus pneumoniae biofilms in a bioreactor with living cultures of human respiratory cells. Infect Immun 81:1341–1353. doi: 10.1128/IAI.01096-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Weimer KE, Armbruster CE, Juneau RA, Hong W, Pang B, Swords WE. 2010. Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease. J Infect Dis 202:1068–1075. doi: 10.1086/656046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Donlan RM, Piede JA, Heyes CD, Sanii L, Murga R, Edmonds P, El-Sayed I, El-Sayed MA. 2004. Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol 70:4980–4988. doi: 10.1128/AEM.70.8.4980-4988.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Parker D, Soong G, Planet P, Brower J, Ratner AJ, Prince A. 2009. The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun 77:3722–3730. doi: 10.1128/IAI.00228-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Moscoso M, Garcia E, Lopez R. 2006. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol 188:7785–7795. doi: 10.1128/JB.00673-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Oggioni MR, Trappetti C, Kadioglu A, Cassone M, Iannelli F, Ricci S, Andrew PW, Pozzi G. 2006. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol Microbiol 61:1196–1210. doi: 10.1111/j.1365-2958.2006.05310.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Qin L, Kida Y, Imamura Y, Kuwano K, Watanabe H. 2013. Impaired capsular polysaccharide is relevant to enhanced biofilm formation and lower virulence in Streptococcus pneumoniae. J Infect Chemother 19:261–271. doi: 10.1007/s10156-012-0495-3. [DOI] [PubMed] [Google Scholar]
- 22.Chao Y, Marks LR, Pettigrew MM, Hakansson AP. 2014. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease. Front Cell Infect Microbiol 4:194. doi: 10.3389/fcimb.2014.00194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Munoz-Elias EJ, Marcano J, Camilli A. 2008. Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Infect Immun 76:5049–5061. doi: 10.1128/IAI.00425-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Trappetti C, Kadioglu A, Carter M, Hayre J, Iannelli F, Pozzi G, Andrew PW, Oggioni MR. 2009. Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host. J Infect Dis 199:1497–1505. doi: 10.1086/598483. [DOI] [PubMed] [Google Scholar]
- 25.Domenech M, Ruiz S, Moscoso M, García E. 2015. In vitro biofilm development of Streptococcus pneumoniae and formation of choline-binding protein-DNA complexes. Environ Microbiol Rep 7:715–727. doi: 10.1111/1758-2229.12295. [DOI] [PubMed] [Google Scholar]
- 26.Trappetti C, Potter AJ, Paton AW, Oggioni MR, Paton JC. 2011. LuxS mediates iron-dependent biofilm formation, competence, and fratricide in Streptococcus pneumoniae. Infect Immun 79:4550–4558. doi: 10.1128/IAI.05644-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yadav MK, Vidal JE, Go YY, Kim SH, Chae SW, Song JJ. 2018. The LuxS/AI-2 quorum-sensing system of Streptococcus pneumoniae is required to cause disease, and to regulate virulence- and metabolism-related genes in a rat model of middle ear infection. Front Cell Infect Microbiol 8:138. doi: 10.3389/fcimb.2018.00138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Vidal JE, Ludewick HP, Kunkel RM, Zahner D, Klugman KP. 2011. The LuxS-dependent quorum-sensing system regulates early biofilm formation by Streptococcus pneumoniae strain D39. Infect Immun 79:4050–4060. doi: 10.1128/IAI.05186-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Trappetti C, Gualdi L, Di Meola L, Jain P, Korir CC, Edmonds P, Iannelli F, Ricci S, Pozzi G, Oggioni MR. 2011. The impact of the competence quorum sensing system on Streptococcus pneumoniae biofilms varies depending on the experimental model. BMC Microbiol 11:75. doi: 10.1186/1471-2180-11-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Akhter F, Womack E, Vidal JE, Le Breton Y, McIver KS, Pawar S, Eichenbaum Z. 2020. Hemoglobin stimulates vigorous growth of Streptococcus pneumoniae and shapes the pathogen’s global transcriptome. Sci Rep 10:15202. doi: 10.1038/s41598-020-71910-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Romero-Espejel ME, Rodríguez MA, Chávez-Munguía B, Ríos-Castro E, Olivares-Trejo JDJ. 2016. Characterization of Spbhp-37, a hemoglobin-binding protein of Streptococcus pneumoniae. Front Cell Infect Microbiol 6:47. doi: 10.3389/fcimb.2016.00047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Shanker E, Federle MJ. 2017. Quorum sensing regulation of competence and bacteriocins in Streptococcus pneumoniae and S. mutans. Genes 8:15. doi: 10.3390/genes8010015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Berry AM, Alexander JE, Mitchell TJ, Andrew PW, Hansman D, Paton JC. 1995. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect Immun 63:1969–1974. doi: 10.1128/IAI.63.5.1969-1974.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Bokori-Brown M, Petrov PG, Khafaji MA, Mughal MK, Naylor CE, Shore AC, Gooding KM, Casanova F, Mitchell TJ, Titball RW, Winlove CP. 2016. Red blood cell susceptibility to pneumolysin: correlation with membrane biochemical and physical properties. J Biol Chem 291:10210–10227. doi: 10.1074/jbc.M115.691899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Shewell LK, Harvey RM, Higgins MA, Day CJ, Hartley-Tassell LE, Chen AY, Gillen CM, James DB, Alonzo F, III, Torres VJ, Walker MJ, Paton AW, Paton JC, Jennings MP. 2014. The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity. Proc Natl Acad Sci U S A 111:E5312–20. doi: 10.1073/pnas.1412703111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Shak JR, Ludewick HP, Howery KE, Sakai F, Yi H, Harvey RM, Paton JC, Klugman KP, Vidal JE. 2013. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. mBio 4:e00655-13. doi: 10.1128/mBio.00655-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Ayoola MB, Shack LA, Nakamya MF, Thornton JA, Swiatlo E, Nanduri B. 2019. Polyamine synthesis effects capsule expression by reduction of precursors in Streptococcus pneumoniae. Front Microbiol 10:1996. doi: 10.3389/fmicb.2019.01996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Embry A, Hinojosa E, Orihuela CJ. 2007. Regions of diversity 8, 9, and 13 contribute to Streptococcus pneumoniae virulence. BMC Microbiol 7:80. doi: 10.1186/1471-2180-7-80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hoover SE, Perez AJ, Tsui HC, Sinha D, Smiley DL, DiMarchi RD, Winkler ME, Lazazzera BA. 2015. A new quorum-sensing system (TprA/PhrA) for Streptococcus pneumoniae D39 that regulates a lantibiotic biosynthesis gene cluster. Mol Microbiol 97:229–243. doi: 10.1111/mmi.13029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Blanchette KA, Shenoy AT, Milner J, II, Gilley RP, McClure E, Hinojosa CA, Kumar N, Daugherty SC, Tallon LJ, Ott S, King SJ, Ferreira DM, Gordon SB, Tettelin H, Orihuela CJ. 2016. Neuraminidase A-exposed galactose promotes Streptococcus pneumoniae biofilm formation during colonization. Infect Immun 84:2922–2932. doi: 10.1128/IAI.00277-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Brown JS, Gilliland SM, Holden DW. 2001. A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence. Mol Microbiol 40:572–585. doi: 10.1046/j.1365-2958.2001.02414.x. [DOI] [PubMed] [Google Scholar]
- 42.Miao X, He J, Zhang L, Zhao X, Ge R, He QY, Sun X. 2018. A novel iron transporter SPD_1590 in Streptococcus pneumoniae contributing to bacterial virulence properties. Front Microbiol 9:1624. doi: 10.3389/fmicb.2018.01624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Tai SS, Yu C, Lee JK. 2003. A solute binding protein of Streptococcus pneumoniae iron transport. FEMS Microbiol Lett 220:303–308. doi: 10.1016/S0378-1097(03)00135-6. [DOI] [PubMed] [Google Scholar]
- 44.Romero-Espejel ME, González-López MA, Olivares-Trejo J.dJ. 2013. Streptococcus pneumoniae requires iron for its viability and expresses two membrane proteins that bind haemoglobin and haem. Metallomics 5:384–389. doi: 10.1039/c3mt20244e. [DOI] [PubMed] [Google Scholar]
- 45.Cheng W, Li Q, Jiang YL, Zhou CZ, Chen Y. 2013. Structures of Streptococcus pneumoniae PiaA and its complex with ferrichrome reveal insights into the substrate binding and release of high affinity iron transporters. PLoS One 8:e71451. doi: 10.1371/journal.pone.0071451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Radhakrishnan D, Yamaguchi M, Kawabata S, Ponnuraj K. 2018. Streptococcus pneumoniae surface adhesin PfbA and its interaction with erythrocytes and hemoglobin. Int J Biol Macromol 120:135–143. doi: 10.1016/j.ijbiomac.2018.08.080. [DOI] [PubMed] [Google Scholar]
- 47.Brooks LRK, Mias GI. 2018. Streptococcus pneumoniae’s virulence and host immunity: aging, diagnostics, and prevention. Front Immunol 9:1366. doi: 10.3389/fimmu.2018.01366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Noske N, Kämmerer U, Rohde M, Hammerschmidt S. 2009. Pneumococcal interaction with human dendritic cells: phagocytosis, survival, and induced adaptive immune response are manipulated by PavA. J Immunol 183:1952–1963. doi: 10.4049/jimmunol.0804383. [DOI] [PubMed] [Google Scholar]
- 49.Hammerschmidt S, Bethe G, Remane PH, Chhatwal GS. 1999. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun 67:1683–1687. doi: 10.1128/IAI.67.4.1683-1687.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Cheng Q, Campbell EA, Naughton AM, Johnson S, Masure HR. 1997. The com locus controls genetic transformation in Streptococcus pneumoniae. Mol Microbiol 23:683–692. doi: 10.1046/j.1365-2958.1997.2481617.x. [DOI] [PubMed] [Google Scholar]
- 51.Kowalko JE, Sebert ME. 2008. The Streptococcus pneumoniae competence regulatory system influences respiratory tract colonization. Infect Immun 76:3131–3140. doi: 10.1128/IAI.01696-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Piñas GE, Cortes PR, Orio AGA, Echenique J. 2008. Acidic stress induces autolysis by a CSP-independent ComE pathway in Streptococcus pneumoniae. Microbiology (Reading) 154:1300–1308. doi: 10.1099/mic.0.2007/015925-0. [DOI] [PubMed] [Google Scholar]
- 53.Sanchez CJ, Kumar N, Lizcano A, Shivshankar P, Dunning Hotopp JC, Jorgensen JH, Tettelin H, Orihuela CJ. 2011. Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production. PLoS One 6:e28738. doi: 10.1371/journal.pone.0028738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Grousd JA, Rich HE, Alcorn JF. 2019. Host-pathogen interactions in Gram-positive bacterial pneumonia. Clin Microbiol Rev 32:e00107-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Lopez CA, Skaar EP. 2018. The impact of dietary transition metals on host-bacterial interactions. Cell Host Microbe 23:737–748. doi: 10.1016/j.chom.2018.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Palmer LD, Skaar EP. 2016. Transition metals and virulence in bacteria. Annu Rev Genet 50:67–91. doi: 10.1146/annurev-genet-120215-035146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Montañez GE, Neely MN, Eichenbaum Z. 2005. The streptococcal iron uptake (Siu) transporter is required for iron uptake and virulence in a zebrafish infection model. Microbiology 151:3749–3757. doi: 10.1099/mic.0.28075-0. [DOI] [PubMed] [Google Scholar]
- 58.Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O. 2004. Iron-source preference of Staphylococcus aureus infections. Science 305:1626–1628. doi: 10.1126/science.1099930. [DOI] [PubMed] [Google Scholar]
- 59.Gaddy JA, Actis LA. 2009. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 4:273–278. doi: 10.2217/fmb.09.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Johnson M, Cockayne A, Morrissey JA. 2008. Iron-regulated biofilm formation in Staphylococcus aureus Newman requires ica and the secreted protein Emp. Infect Immun 76:1756–1765. doi: 10.1128/IAI.01635-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Anderson GG, Moreau-Marquis S, Stanton BA, O’Toole GA. 2008. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect Immun 76:1423–1433. doi: 10.1128/IAI.01373-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Banin E, Vasil ML, Greenberg EP. 2005. Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci U S A 102:11076–11081. doi: 10.1073/pnas.0504266102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Damrose JF, Maddalozzo J. 2006. Pediatric epistaxis. Laryngoscope 116:387–393. doi: 10.1097/01.MLG.0000195369.01289.9B. [DOI] [PubMed] [Google Scholar]
- 64.Pynnonen M, Stephenson RE, Schwartz K, Hernandez M, Boles BR. 2011. Hemoglobin promotes Staphylococcus aureus nasal colonization. PLoS Pathog 7:e1002104. doi: 10.1371/journal.ppat.1002104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Schlosser RJ. 2009. Clinical practice: epistaxis. N Engl J Med 360:784–789. doi: 10.1056/NEJMcp0807078. [DOI] [PubMed] [Google Scholar]
- 66.Pendrak ML, Yan SS, Roberts DD. 2004. Sensing the host environment: recognition of hemoglobin by the pathogenic yeast Candida albicans. Arch Biochem Biophys 426:148–156. doi: 10.1016/j.abb.2004.02.006. [DOI] [PubMed] [Google Scholar]
- 67.Yadav MK, Kwon SK, Cho CG, Park SW, Chae SW, Song JJ. 2012. Gene expression profile of early in vitro biofilms of Streptococcus pneumoniae. Microbiol Immunol 56:621–629. doi: 10.1111/j.1348-0421.2012.00483.x. [DOI] [PubMed] [Google Scholar]
- 68.Brown LR, Caulkins RC, Schartel TE, Rosch JW, Honsa ES, Schultz-Cherry S, Meliopoulos VA, Cherry S, Thornton JA. 2017. Increased zinc availability enhances initial aggregation and biofilm formation of Streptococcus pneumoniae. Front Cell Infect Microbiol 7:233. doi: 10.3389/fcimb.2017.00233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Dawid S, Sebert ME, Weiser JN. 2009. Bacteriocin activity of Streptococcus pneumoniae is controlled by the serine protease HtrA via posttranscriptional regulation. J Bacteriol 191:1509–1518. doi: 10.1128/JB.01213-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Halfmann A, Schnorpfeil A, Muller M, Marx P, Gunzler U, Hakenbeck R, Bruckner R. 2011. Activity of the two-component regulatory system CiaRH in Streptococcus pneumoniae R6. J Mol Microbiol Biotechnol 20:96–104. doi: 10.1159/000324893. [DOI] [PubMed] [Google Scholar]
- 71.Mascher T, Heintz M, Zahner D, Merai M, Hakenbeck R. 2006. The CiaRH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in beta-lactam resistance. J Bacteriol 188:1959–1968. doi: 10.1128/JB.188.5.1959-1968.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Sebert ME, Palmer LM, Rosenberg M, Weiser JN. 2002. Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun 70:4059–4067. doi: 10.1128/iai.70.8.4059-4067.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.O’Brien KL, Bronsdon MA, Dagan R, Yagupsky P, Janco J, Elliott J, Whitney CG, Yang YH, Robinson LG, Schwartz B, Carlone GM. 2001. Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol 39:1021–1024. doi: 10.1128/JCM.39.3.1021-1024.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. doi: 10.1186/gb-2009-10-3-r25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Liao Y, Smyth GK, Shi W. 2014. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923–930. doi: 10.1093/bioinformatics/btt656. [DOI] [PubMed] [Google Scholar]
- 76.Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Wu X, Gordon O, Jiang W, Antezana BS, Angulo-Zamudio UA, Del Rio C, Moller A, Brissac T, Tierney ARP, Warncke K, Orihuela CJ, Read TD, Vidal JE. 2019. Interaction between Streptococcus pneumoniae and Staphylococcus aureus Generates ·OH radicals that rapidly kill Staphylococcus aureus strains. J Bacteriol 201:e00474-19. doi: 10.1128/JB.00474-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Havarstein LS, Coomaraswamy G, Morrison DA. 1995. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc Natl Acad Sci U S A 92:11140–11144. doi: 10.1073/pnas.92.24.11140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Avery OT, Macleod CM, McCarty M. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 79:137–158. doi: 10.1084/jem.79.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Lanie JA, Ng WL, Kazmierczak KM, Andrzejewski TM, Davidsen TM, Wayne KJ, Tettelin H, Glass JI, Winkler ME. 2007. Genome sequence of Avery’s virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6. J Bacteriol 189:38–51. doi: 10.1128/JB.01148-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, Durkin AS, Gwinn M, Kolonay JF, Nelson WC, Peterson JD, Umayam LA, White O, Salzberg SL, Lewis MR, Radune D, Holtzapple E, Khouri H, Wolf AM, Utterback TR, Hansen CL, McDonald LA, Feldblyum TV, Angiuoli S, Dickinson T, Hickey EK, Holt IE, Loftus BJ, Yang F, Smith HO, Venter JC, Dougherty BA, Morrison DA, Hollingshead SK, Fraser CM. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498–506. doi: 10.1126/science.1061217. [DOI] [PubMed] [Google Scholar]
- 82.Nieto C, Espinosa M. 2003. Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein. Plasmid 49:281–285. doi: 10.1016/s0147-619x(03)00020-9. [DOI] [PubMed] [Google Scholar]
- 83.Perez-Casal J, Price JA, Maguin E, Scott JR. 1993. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol Microbiol 8:809–819. doi: 10.1111/j.1365-2958.1993.tb01628.x. [DOI] [PubMed] [Google Scholar]
- 84.Chaffin DO, Rubens CE. 1998. Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. Gene 219:91–99. doi: 10.1016/s0378-1119(98)00396-5. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
We have deposited all RNA-Seq raw sequencing reads with the Sequence Read Archive at the National Center for Biotechnology Institute (accession number PRJNA642413) for public availability.





